JACOB SELLERS: Open Payments
NPI 1326696071 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,246 in 102 payments from 21 companies in 2025. Trend: 2023 $3,128 · 2024 $1,186 · 2025 $2,246
Food & beverage: $2,148Education: $97
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $350 |
| GENZYME CORPORATION | 10 | $254 |
| Actelion Pharmaceuticals US, Inc. | 10 | $241 |
| Regeneron Healthcare Solutions, Inc. | 11 | $229 |
| AstraZeneca Pharmaceuticals LP | 10 | $217 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $212 |
| Amgen Inc. | 6 | $137 |
| Verona Pharma, Inc. | 4 | $120 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Merck Sharp & Dohme LLC | 4 | $76 |
Products named: DUPIXENT, NUCALA, LUMRYZ, TEZSPIRE, OPSUMIT, Ohtuvayre, TRELEGY ELLIPTA, Sunosi.
Industry payments across GA — which companies pay providers there.
